Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

v3.20.2
Equity (Tables)
9 Months Ended
Sep. 30, 2020
Equity (Tables) [Line Items]  
Schedule of stock option activities
(in thousands, except for per-share amounts)   Number of Shares     Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term
(in years)
    Aggregate
Intrinsic
Value
 
Outstanding, December 31, 2019     380     $ 35.10       7.88     $ -  
Granted     390       9.69                  
Cancelled     (20 )     16.12                  
Outstanding, September 30, 2020     750       22.43       8.61       444  
                                 
Exercisable, September 30, 2020     216       51.98       6.54       109  
Pre-funded Warrants [Member]  
Equity (Tables) [Line Items]  
Schedule of warrant activities
(in thousands, except for per-share amounts)   Number of Shares     Weighted
Average
Exercise
Price
    Aggregate
Intrinsic
Value
 
Outstanding, December 31, 2019     -     $ -     $ -  
Granted     3,459       0.003          
Exercised     (1,611 )     0.003          
Outstanding, September 30, 2020     1,848     $ 0.003     $ 17,900  
                         
Exercisable, September 30, 2020     1,848     $ 0.003     $ 17,900  
Warrant [Member]  
Equity (Tables) [Line Items]  
Schedule of stock option activities
(in thousands, except for per-share amounts)   Number of Shares     Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term
(in years)
    Aggregate
Intrinsic
Value
 
Outstanding, December 31, 2019     2,871     $ 20.71       2.95     $ 301  
Granted     -       -                  
Exercised     (2 )     15.00                  
Cancelled/Expired     (756 )     21.00                  
Outstanding, September 30, 2020     2,113     $ 20.61       3.01     $ 454  
                                 
Exercisable, September 30, 2020     2,111     $ 20.62       3.01     $ 454